Clinical Reflections®: Achieving Success in RA Assessment and Management: A Learner Pathway to Improve Patient Outcomes

Program Overview

This unique educational initiative harnesses the power of reflection and recognition of suboptimal approaches to patient management to allow you to rethink clinical decisions based on the scenarios presented and to modify management plans accordingly. You can compare your responses to interactive questions with those of your peers and learn from our expert faculty.

Credit Expired

CE Credit Expired

Target Audience

Rheumatologists – Relevant Terms: Rheumatoid Arthritis

Educational Objectives

Upon completion of this activity, participants should be better able to:

Discriminate between the effects of the tumor necrosis factor alpha (TNFα) and interleukin 6 (IL-6) signaling pathways in the pathophysiology of rheumatoid arthritis (RA) and provide a rationale for anti-cytokine therapy as a treatment approach
Incorporate validated and guideline-recommended disease activity monitoring to guide appropriate management for patients with rheumatoid arthritis
Develop individualized treatment plans for patients with rheumatoid arthritis that integrate new and emerging targeted and non-TNF disease modifying antirheumatic drugs (bMARDs) based on safety and efficacy data
Distinguish between TNF cycling and switching and prepare treatment plans that improve patient outcomes based on an understanding of the differences between the 2 options
Integrate shared decision making and other patient education strategies for patients with rheumatoid arthritis

Activity Faculty

Jeffrey R. Curtis, MD, MS, MPH (Chair)

William J. Koopman Endowed Professor, Rheumatology and Immunology
Professor, Medicine, Division of Clinical Immunology and Rheumatology
Director, University of Alabama at Birmingham (UAB) Arthritis Clinical Intervention Program
Co-Director, UAB Center for Education and Research on Therapeutics (CERTS) of Musculoskeletal Disorders
Co-Director, UAB Pharmacoepidemiology and Pharmacoeconomics (PEER) Unit
University of Alabama at Birmingham
Birmingham, AL

Martin Jan Bergman, MD, FACR, FACP, FCPP

Clinical Associate Professor, Medicine
Drexel University School of Medicine
Philadelphia, PA
Chief, Division of Rheumatology
Taylor Hospital
Ridley Park, PA

Peter C. Taylor, MA, BM, BCh, PhD, FRCP, FRCPE

Norman Collison Professor, Musculoskeletal Sciences
Fellow, St. Peter’s College
Head, Clinical Sciences, Biomedical Research Unit Inflammation Theme
Botnar Research Centre
University of Oxford
Oxford, England (UK)

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Featured RMEI CE Activities

Advances in Precision Medicine for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Care

Closing the Gap: Personalized Approaches to Cervical Cancer Screening and Treatment

Privacy | Terms of Use